Seres Therapeutics, Inc. — Director's Dealing 2023

Jun 23, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Seres Therapeutics, Inc. (MCRB)
CIK: 0001609809
Period of Report: 2023-06-22

Reporting Person: Ausiello Dennis A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-22	Stock Option (right to buy)	$5.46	A	35000	Acquired	2033-06-21	Common Stock (35000)	Direct

Footnotes

F1: The option vests in full on the earlier of June 22, 2024 or the day immediately prior to the company's 2024 annual meeting of shareholders.